Healthcare Outcomes Performance Company (HOPCo) is adding Philadelphia Hand to Shoulder Center to its musculoskeletal (MSK) practice management platform and as a partner with Premier Orthopaedics.
HOPCo Adds Philadelphia Hand to Shoulder Center

Philadelphia Hand to Shoulder Center offers orthopedic care for hands, wrists, arms, elbows, and shoulders from 15 locations in Pennsylvania and New Jersey. It is one of the largest practices of its kind in the U.S.
Premier Orthopaedics provides orthopedic services from over 35 locations in the Greater Philadelphia region. Together, Philadelphia Hand to Shoulder Center and Premier Orthopaedics will have more than 50 locations and over 265 MSK providers. Per the press release, this partnership creates one of the largest integrated MSK platforms in Pennsylvania and the U.S.
Philadelphia Hand to Shoulder Center CEO Patrick Kane, M.D. commented, “We see this partnership as an opportunity to grow not just in size and efficiencies but also in our ability to continue to deliver excellent patient care across a larger platform.”
Dr. Kane continued, “Our partnership with Premier Orthopaedics will allow us to provide more comprehensive care for our patients across the entire musculoskeletal spectrum. At the same time, joining HOPCo will allow us access to a larger infrastructure that will help accelerate our growth and lead further efforts in value-based care.”
HOPCo is a leading healthcare management company. According to the press release, both practices will now have access to “the full extent of HOPCo’s proprietary tools and analytics infrastructure.”
OTW spoke with HOPCo President and Chief Transformation Officer Wael Barsoum, M.D. about HOPCo’s plans for continued growth for 2023. Dr. Barsoum told OTW, “In 2023, we aim to expand our partnerships in the states where our platforms currently operate, including Arizona, Nevada, Oregon, Michigan, Wisconsin, Florida, North Carolina, Pennsylvania and New Jersey.”
Dr. Barsoum continued, “At the same time, we are already in discussion with physician practices and health systems in many other states who have recognized the success of our existing partners and are interested in becoming MSK value-based care leaders in their own markets.”
Earlier in 2022 Premier Orthopaedics and HOPCo announced a partnership. For OTW’s coverage of the partnership, see “Premier Orthopaedics Partners With HOPCo.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.